About the session:
Getting IRT wrong can have big ramifications for your clinical trial. Even an IRT that works but is not optimized can have time, resource, and budget implications. As with other disciplines in clinical development, IRT must be recognized as something that requires dedicated experts with both a deep and broad knowledge of the technology and its application. This presentation will describe what expertise looks like, why it is important, why built-for-purpose matters, and the benefits of in-house expertise.
We can’t wait to talk more to you about your current e-technical needs.
发言人
Craig Mooney
Vice President, Scientific E-tech Enabled Services, Calyx
Craig Mooney has nearly 30 years’ experience in the clinical development industry, with concentrated focus on optimizing IRT to improve clinical trial efficiencies. Craig brings a unique understanding of IRT from both a delivery and user perspective, having served as the Director of IRT at Bristol-Myers Squibb for most of the past decade and having held roles in clinical operations, IMP packaging, and labeling & logistics. He is considered an industry expert and has been a featured speaker at numerous IRT conferences including positions as Conference Chairman.
